NCT06017726View on ClinicalTrials.gov

Insulin Resistance in Egyptian Patients With Multiple Sclerosis

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Multiple SclerosisInsulin Resistance
Interventions
OTHER

treatment of insulin resistance with appropriate modality according to each patient

insulin resistance will be treated with either diet alone or combined diet and appropriate pharmacological treatment with the net result of normalization of HOMA IR index

All Listed Sponsors
lead

Assiut University

OTHER

NCT06017726 - Insulin Resistance in Egyptian Patients With Multiple Sclerosis | Biotech Hunter | Biotech Hunter